Selenious acid - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for selenious acid and what is the scope of patent protection?
Selenious acid
is the generic ingredient in one branded drug marketed by Am Regent and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.Selenious acid has six patent family members in six countries.
One supplier is listed for this compound.
Summary for selenious acid
International Patents: | 6 |
US Patents: | 1 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 55 |
Clinical Trials: | 3 |
Patent Applications: | 2,070 |
What excipients (inactive ingredients) are in selenious acid? | selenious acid excipients list |
DailyMed Link: | selenious acid at DailyMed |
Recent Clinical Trials for selenious acid
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
American Regent, Inc. | Phase 4 |
Shanghai Zhongshan Hospital | N/A |
Shanghai Changzheng Hospital | N/A |
Paragraph IV (Patent) Challenges for SELENIOUS ACID
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
SELENIOUS ACID | Intravenous Solution | selenious acid | 600 mcg/10 mL | 209379 | 11 | 2024-06-11 |
US Patents and Regulatory Information for selenious acid
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Am Regent | SELENIOUS ACID | selenious acid | SOLUTION;INTRAVENOUS | 209379-003 | Aug 30, 2021 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Am Regent | SELENIOUS ACID | selenious acid | SOLUTION;INTRAVENOUS | 209379-001 | Apr 30, 2019 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Am Regent | SELENIOUS ACID | selenious acid | SOLUTION;INTRAVENOUS | 209379-002 | Jan 25, 2021 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Am Regent | SELENIOUS ACID | selenious acid | SOLUTION;INTRAVENOUS | 209379-002 | Jan 25, 2021 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Am Regent | SELENIOUS ACID | selenious acid | SOLUTION;INTRAVENOUS | 209379-001 | Apr 30, 2019 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for selenious acid
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 2021300384 | Trace element compositions, methods of making and use | ⤷ Sign Up |
South Korea | 20230058047 | 미량 원소 조성물, 그 제조 및 사용 방법 | ⤷ Sign Up |
China | 116096423 | 微量元素组合物、制备方法及应用 (Microelement composition, preparation method and application) | ⤷ Sign Up |
European Patent Office | 4175615 | COMPOSITIONS D'OLIGO-ÉLÉMENTS, LEURS PROCÉDÉS DE FABRICATION ET D'UTILISATION (TRACE ELEMENT COMPOSITIONS, METHODS OF MAKING AND USE) | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 2022006426 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |